<div><div></div><div><span><p><span>On November 14, 2025, Minerva Neurosciences, Inc. announced the appointment of Inderjit Kaul, M.D., MPH as a new director. Dr. Kaul will serve as a Class II director with a term expiring at the 2025 Annual Meeting of Stockholders.</span></p><div><table><tbody><tr><td><strong><span>Individual</span></strong></td><td><span>Inderjit Kaul, M.D., MPH</span></td></tr><tr><td><strong><span>Role</span></strong></td><td><span>Director</span></td></tr><tr><td><strong><span>Type of Change</span></strong></td><td><span>Appointed</span></td></tr><tr><td><strong><span>Effective Date</span></strong></td><td><span>November 14, 2025</span></td></tr><tr><td><strong><span>Reason</span></strong></td><td><span>Board expansion</span></td></tr><tr><td><strong><span>Replacement Info</span></strong></td><td><span>Not applicable</span></td></tr><tr><td><strong><span>Background Details</span></strong></td><td><span>Not disclosed</span></td></tr><tr><td><strong><span>Board/Committee Role Changes</span></strong></td><td><span>Not disclosed</span></td></tr></tbody></table></div><p><span>Original SEC Filing: </span>Minerva Neurosciences, Inc. [ NERV ] - 8-K - Nov. 19, 2025</p><section><b><span class="heading-aHOVUrmQ">Disclaimer</span></b><div><span>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</span></div></section></span></div></div>

NERV

<p>Minerva Neurosciences, Inc. announced the appointment of Inderjit Kaul, M.D., MPH as a new Class II director, effective November 14, 2025. Dr. Kaul's term will expire at the 2025 Annual Meeting of Stockholders. This appointment is part of a board expansion. Further details about Dr. Kaul's background and board role changes were not disclosed.</p>

Minerva Neurosciences Appoints New Director